China · Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 11.05 billion. The enterprise value is 9.44 billion.
| Market Cap | 11.05B |
| Enterprise Value | 9.44B |
Important Dates
The last earnings date was Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
SHE:301087 has 230.20 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 203.20M |
| Shares Outstanding | 230.20M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +1.46% |
| Owned by Insiders (%) | 10.10% |
| Owned by Institutions (%) | 14.69% |
| Float | 109.75M |
Valuation Ratios
The trailing PE ratio is 26.82 and the forward PE ratio is 22.83. SHE:301087's PEG ratio is 1.35.
| PE Ratio | 26.82 |
| Forward PE | 22.83 |
| PS Ratio | 3.02 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.70 |
| P/FCF Ratio | 20.25 |
| P/OCF Ratio | 16.05 |
| PEG Ratio | 1.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.27, with an EV/FCF ratio of 17.30.
| EV / Earnings | 24.37 |
| EV / Sales | 2.58 |
| EV / EBITDA | 17.27 |
| EV / EBIT | 26.11 |
| EV / FCF | 17.30 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.21.
| Current Ratio | 2.07 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.87 |
| Debt / FCF | 1.87 |
| Interest Coverage | 22.50 |
Financial Efficiency
Return on equity (ROE) is 7.98% and return on invested capital (ROIC) is 9.78%.
| Return on Equity (ROE) | 7.98% |
| Return on Assets (ROA) | 3.39% |
| Return on Invested Capital (ROIC) | 9.78% |
| Return on Capital Employed (ROCE) | 7.37% |
| Weighted Average Cost of Capital (WACC) | 7.81% |
| Revenue Per Employee | 720,739 |
| Profits Per Employee | 76,210 |
| Employee Count | 5,081 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, SHE:301087 has paid 59.29 million in taxes.
| Income Tax | 59.29M |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +49.75% in the last 52 weeks. The beta is 0.76, so SHE:301087's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +49.75% |
| 50-Day Moving Average | 55.92 |
| 200-Day Moving Average | 47.31 |
| Relative Strength Index (RSI) | 39.39 |
| Average Volume (20 Days) | 3,385,390 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.66 billion and earned 387.23 million in profits. Earnings per share was 1.88.
| Revenue | 3.66B |
| Gross Profit | 1.94B |
| Operating Income | 361.42M |
| Pretax Income | 445.45M |
| Net Income | 387.23M |
| EBITDA | 478.71M |
| EBIT | 361.42M |
| Earnings Per Share (EPS) | 1.88 |
Balance Sheet
The company has 2.67 billion in cash and 1.02 billion in debt, with a net cash position of 1.65 billion or 7.17 per share.
| Cash & Cash Equivalents | 2.67B |
| Total Debt | 1.02B |
| Net Cash | 1.65B |
| Net Cash Per Share | 7.17 |
| Equity (Book Value) | 4.77B |
| Book Value Per Share | 22.99 |
| Working Capital | 2.15B |
Cash Flow
In the last 12 months, operating cash flow was 688.23 million and capital expenditures -142.72 million, giving a free cash flow of 545.51 million.
| Operating Cash Flow | 688.23M |
| Capital Expenditures | -142.72M |
| Depreciation & Amortization | 117.29M |
| Net Borrowing | 147.20M |
| Free Cash Flow | 545.51M |
| FCF Per Share | 2.37 |
Margins
Gross margin is 53.03%, with operating and profit margins of 9.87% and 10.57%.
| Gross Margin | 53.03% |
| Operating Margin | 9.87% |
| Pretax Margin | 12.16% |
| Profit Margin | 10.57% |
| EBITDA Margin | 13.07% |
| EBIT Margin | 9.87% |
| FCF Margin | 14.90% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.48%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 95.85% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 3.57% |
| Earnings Yield | 3.50% |
| FCF Yield | 4.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |